Cargando…
Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier
Antibody, immuno- and gene therapies developed for neurological indications face a delivery challenge posed by various anatomical and physiological barriers within the central nervous system (CNS); most notably, the blood–brain barrier (BBB). Emerging delivery technologies for biotherapeutics have f...
Autores principales: | Stanimirovic, Danica B., Sandhu, Jagdeep K., Costain, Will J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290705/ https://www.ncbi.nlm.nih.gov/pubmed/30306341 http://dx.doi.org/10.1007/s40259-018-0309-y |
Ejemplares similares
-
Proteome of the Luminal Surface of the Blood–Brain Barrier
por: Hill, Jennifer J., et al.
Publicado: (2021) -
Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier
por: Shin, Jung-Won, et al.
Publicado: (2022) -
Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies
por: Rossi, Luigia, et al.
Publicado: (2020) -
May the Force Be With You: The Light and Dark Sides of the Microbiota–Gut–Brain Axis in Neuropsychiatry
por: Sherwin, Eoin, et al.
Publicado: (2016) -
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
por: Neys, Stefan F. H., et al.
Publicado: (2021)